Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Daily Low-Dose Tadalafil

Tadalafil 2.5-5 mg Once Daily for ED and BPH

Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
FDA Approved (once-daily use, 2008-2011)

Reference only. Not medical advice.

What can go wrong

Same class risks as all PDE5 inhibitors: absolutely contraindicated with nitrates (risk of severe hypotension) and used with caution with alpha-blockers. Common effects include headache, back/muscle aches (more characteristic of tadalafil), flushing, dyspepsia, and nasal congestion. Daily dosing means continuous exposure, so drug interactions and contraindications apply every day, not just before sex.

This is something to take to a clinician. The Atlas can tell you what is known about daily low-dose tadalafil in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Taken every day at 2.5-5 mg, tadalafil keeps PDE5 continuously inhibited so erections become possible at any time without dose timing, the appeal being spontaneity rather than a scheduled pill. The FDA approved Cialis for once-daily use for ED, and in October 2011 expanded the daily indication to the signs and symptoms of benign prostatic hyperplasia (BPH) and to men who have both ED and BPH. This dual benefit makes daily 5 mg tadalafil a common choice for older men with lower urinary tract symptoms plus erectile difficulty.

The two-birds option for men with both ED and an enlarged prostate.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Daily ED treatment for spontaneity
  • BPH / lower urinary tract symptoms
  • Men with both ED and BPH (single drug)

How it works

Tadalafil inhibits PDE5, sustaining cGMP and smooth-muscle relaxation in the penis. Its long half-life (~17.5 hours) means a small daily dose maintains steady-state inhibition around the clock. The same smooth-muscle relaxation in the prostate and bladder neck is thought to relieve BPH-related urinary symptoms.

Steady state
~5 days of daily dosing
Spontaneity
No timing to sexual activity
Onset (as-needed equivalent)
30-45 min

How it is taken

Typically started at 5 mg once daily, taken at roughly the same time each day; 2.5 mg is an option for some patients. Steady-state coverage develops over about five days. Dose adjustments are needed in renal impairment.

Safety in detail

This is a prescription drug with an absolute nitrate contraindication. It involves real cardiovascular and drug-interaction considerations and requires evaluation and monitoring by a qualified physician. Self-sourcing without medical oversight carries documented health risks.

What has to be monitored

The bloodwork this needs, and the reason it belongs with a clinician rather than a website.

  • Concurrent nitrate or guanylate-cyclase-stimulator use
  • Alpha-blocker / antihypertensive co-use and orthostatic symptoms
  • Cardiovascular fitness for sexual activity
  • Renal function for dose adjustment

What people get wrong

  • Often saidDaily dosing builds up a stronger erection over time

    ActuallyIt provides steady readiness, not escalating potency. The benefit is spontaneity and coverage, not a bigger effect than the as-needed dose.

  • Often saidIt's safer because the dose is small

    ActuallyThe dose is smaller per pill, but exposure is continuous, so the nitrate contraindication and interactions apply every single day.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

Set against the alternatives

Versus as-needed sildenafil or tadalafil, daily dosing trades a steady-state convenience and BPH benefit for continuous drug exposure and (often) higher cumulative cost. It is the standard PDE5 choice when a man has both ED and bothersome urinary symptoms.

At a glance

Daily dose
2.5-5 mg
Half-life
~17.5 hours
Once-daily ED approval
2008
BPH / ED+BPH approval
October 2011
Generic
Yes

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Daily Low-Dose Tadalafil. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Cialis once-daily ED program2008

    Demonstrated efficacy of continuous low-dose tadalafil for ED, supporting the daily indication

  • Tadalafil BPH/LUTS trials2011

    Once-daily 5 mg improved lower urinary tract symptoms, supporting FDA approval for BPH and ED+BPH